Risk factors
Adagio Medical Holdings (ADGM) risk factors
Item 1A of every Adagio Medical Holdings, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
69 risks, 13 new, 12 dropped, 13 reworded since the prior year. Adagio Medical highlights ongoing clinical development risks, particularly for the FULCRUM-VT trial and vCLAS Cryoablation System.
Filed Mar 27, 2026 - FY2024 10-K risk factors
68 risks. Adagio Medical faces severe going concern doubts, zero meaningful revenue, and heavy losses while developing its vCLAS catheter.
Filed Mar 27, 2025